Silverback Therapeutics Inc

NASDAQ:SBTX   3:59:41 PM EDT
38.76
+0.47 (+1.23%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Silverback Therapeutics, Inc. Stock, NASDAQ:SBTX

500 Fairview Avenue North, Suite 600, Seattle, Washington 98109
United States of America
Phone: +1.206.456.2900
Number of Employees:

Description

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson on January 4, 2016 and is headquartered in Seattle, WA.